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Abstract 
Chromosomal instability is a hallmark of cancer, but mitotic regulators are 
rarely mutated in tumours. Mutations in the condensin complexes, which 
restructure chromosomes to facilitate segregation during mitosis, are 
significantly enriched in cancer genomes, but experimental evidence 
implicating condensin dysfunction in tumourigenesis is lacking. We report that 
mice inheriting missense mutations in a condensin II subunit (Caph2nes) 
develop T cell lymphoma. Before tumours develop, we find that the same 
Caph2 mutation impairs ploidy maintenance to a different extent in different 
haematopoietic cell types, with ploidy most severely perturbed at the 
CD4+CD8+ T cell stage from which tumours initiate. Premalignant CD4+CD8+ 
T cells show persistent catenations during chromosome segregation, 
triggering DNA damage in diploid daughter cells and elevated ploidy. Genome 
sequencing revealed that Caph2 single mutant tumours are near diploid but 
carry deletions spanning tumour suppressor genes, whereas P53 inactivation 
allowed Caph2 mutant cells with whole chromosome gains and structural 
rearrangements to form highly aggressive disease. Together, our data 
challenge the view that mitotic chromosome formation is an invariant process 
during development, and provide evidence that defective mitotic chromosome 
structure can promote tumourigenesis. 
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Introduction 
Genome integrity is maintained by molecular machines that drive the 
duplication and segregation of the genome, and by checkpoints that monitor 
for incorrect execution of these processes. As cells enter mitosis, 
chromosomes undergo profound structural changes, which are driven by 
topoisomerase II and condensins (Swedlow and Hirano 2003). This process 
removes catenations between sister chromatids, generates stiff rod-like 
structures that are competent for chromosome segregation, and is essential 
for genome propagation through the cell cycle in all eukaryotes.  
 Condensins belong to the structural maintenance of chromosomes 
(SMC) complex family that also includes cohesin and SMC5/6. In eukaryotes, 
each SMC complex contains a heterodimer of SMC ATPase subunits, a single 
kleisin subunit and additional accessory factors (Nasmyth and Haering 2005; 
Losada and Hirano 2005) (Figure 1A). Within cohesin and condensin 
complexes, the carboxy and amino termini of kleisin interact with apposing 
SMC subunits to form a tripartite, asymmetric ring-like structure that can 
entrap DNA (Gruber et al. 2003; Onn et al. 2007; Cuylen et al. 2011; Piazza et 
al. 2014; Nasmyth and Oliveira 2010). This mode of association has been 
proposed to allow SMC complexes to form topological linkages between 
chromosomes, or between different regions on the same DNA molecule. 
Metazoan genomes encode at least two distinct condensin complexes 
(Ono et al. 2003), which play non-redundant and incompletely understood 
roles in the regulation of chromosome architecture (Ono et al. 2003; Green et 
al. 2012; Hirano 2012; Houlard et al. 2015; Nishide and Hirano 2014). 
	 	 Woodward		
	
4	
4	
Condensin I gains access to chromosomes between prometaphase and 
telophase, whereas condensin II is present in both the nucleus and cytoplasm 
during interphase and becomes concentrated on chromosome axes and 
centromeres during prophase (Hirota et al. 2004; Ono et al. 2004). Loss of 
condensin I results in shorter wider mitotic chromosomes, whereas loss of 
condensin II produces long chromosomes with reduced axial rigidity (Ono et 
al. 2003; Shintomi and Hirano 2011; Green et al. 2012).  
Chromosome structure and mitotic fidelity are compromised in many 
cancers, which leads to numerical and structural chromosome abnormalities 
and DNA damage. The underlying causes of abnormal mitosis in cancer are 
not well understood, and it is notable that mutations in known mitotic 
regulators do not occur at high frequency in cancer genomes. However, 
successful mitosis requires the concerted activity of hundreds of genes 
(Neumann et al. 2010). Biologically significant mutations could therefore be 
distributed across a large number of loci at relatively low frequency per gene. 
Evidence supporting this hypothesis recently arose from a gene-network-
based analysis of The Cancer Genome Atlas (TCGA) dataset (Leiserson et al. 
2014). With the exception of SMC4, mutations in condensin subunits were not 
statistically enriched in tumour genomes when considered individually; 
however, statistical significance was reached when subunits were considered 
together as a single functional entity, reflecting their concerted activity in the 
cell.  
Previous mouse models of condensin deficiency have focused primarily on 
loss of function mutations (Smith et al. 2004; Nishide and Hirano 2014; 
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Houlard et al. 2015), which cause chromosome segregation failure followed 
by cellular and organismal lethality. However, the majority of condensin 
mutations in TCGA are missense, and likely to exert sub-lethal effects on 
chromosome structure. To directly assess the consequences of hypomorphic 
condensin II deficiency on development and disease, we have studied a 
viable mouse model carrying a constitutive missense mutation in the 
condensin II kleisin-β subunit Caph2 (Caph2nes). These mice were previously 
reported to exhibit a block during T cell development resulting in thymic 
hypoplasia and reduced numbers of circulating T cells (Gosling et al. 2007). 
During T cell differentiation in wildtype mice, the earliest thymic progenitors do 
not express T cell receptor (TCR) and are double negative (DN) for CD4 and 
CD8. Successful VDJ recombination at the TCRβ-chain locus leads to 
progression through the β-selection checkpoint and rapid proliferation, during 
which cells upregulate CD4 and CD8 to become double positive (DP). These 
rapidly proliferating early DP cells express the transferrin receptor CD71 (DP 
CD71+), but this marker is downregulated upon cell cycle exit (DP CD71-) 
(Brekelmans et al. 1994), when rearrangement of the TCRα chain locus is 
completed. In Caph2nes/nes mice, T cell development is blocked at the 
transition from DN to DP (Gosling et al. 2007), but the cellular defects and 
their consequences during aging have not been characterised. We find that 
Caph2nes/nes mice develop thymic lymphomas with high penetrance, then 
identify the cell of origin and characterise the cytological and genomic 
abnormalities that drive condensin II-dependent tumour formation. Our data 
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provide direct experimental evidence that perturbation of the mitotic 
chromosome condensation apparatus can promote tumourigenesis.  
 
Results 
Caph2 mutation causes thymic lymphoma 
The Caph2nes allele (I15N) replaces an evolutionarily conserved hydrophobic 
amino acid for a polar residue in the N-terminus of Caph2 (Figure S1A). 
Based on available crystal structures (Bürmann et al. 2013; Kamada et al. 
2013), the equivalent residue (I22) in prokaryotic condensins is largely buried 
and positioned within the first α-helix of the kleisin subunit (ScpA - Figure 1A 
& B). As reported previously (Gosling et al. 2007), the thymus and spleen of 
young Caph2nes/nes adults showed a marked reduction in T lymphocytes. 
Although Caph2nes/nes mice had lower body weight and reduced brain size 
compared to littermate controls (Martin et al, accepted at Genes & 
Development), the development of lymphoid organs was disproportionately 
affected (Figure S1B).  
To determine whether sub-lethal condensin II perturbation predisposes 
to cancer, a cohort of Caph2nes/nes mice was aged for 15 months. Necropsy 
revealed lymphoma in 9 of 9 aged individuals compared to 0 of 8 controls 
(Fisher’s exact p < 1 x 10-4, Figure 1C). Other than a single case of 
leiomyosarcoma in a Caph2nes/nes animal with concurrent lymphoma, no other 
tumours were identified upon necropsy. More than half of the Caph2nes/nes 
cohort became terminally ill within the 15 month study period (Log rank p < 
0.02, Figure 1C). Lymphoma cells typically took over the thymus, spleen and 
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lymph nodes, and infiltrated lungs, kidneys and liver (Figure S1B and data not 
shown). Lymphoma cells were either CD4+CD8+ double positive (DP) or 
CD4loCD8+ (Figure 1D), revealing their origin from thymic T progenitor cells 
that had progressed through the TCRβ-selection checkpoint.  
The cell cycles following thymic β-selection are known to be particularly 
vulnerable to genomic instability, because the most rapid spontaneous 
tumours to develop in P53 null mice are lymphomas with a CD4+CD8+ and 
immature CD4loCD8+ immunophenotype (Donehower et al. 1992; Jacks et al. 
1994). To assess the role of P53 during Caph2-dependent lymphomagenesis, 
Caph2nes/nes; P53-/- double homozygous mutants (hereafter “double mutants”) 
were derived by intercrossing Caph2nes/nes; P53+/- parents. Double mutants 
were recovered at approximately Mendelian ratios (19% at weaning, n = 121, 
Fisher’s exact p = 0.35).  
To monitor the early stages of tumour development, we made use of 
the fact that each T cell undergoing β-selection carries a unique 
rearrangement at the T Cell Receptor β (TCRβ) locus. This can be used as a 
molecular barcode to quantify clonal expansion, where the proportion of 
identical V-D-J sequences detectable in genomic DNA from the thymus 
should increase (Supplemental Methods) (Dudgeon et al. 2014). Such 
increases can be detected by deep sequencing of PCR amplicons spanning 
the variable to constant regions of the TCRβ locus (Dudgeon et al. 2014).  At 
three weeks post partum (pp), the highest proportion of replicated T cell 
clones in the thymus of wildtype, Caph2nes/nes, or P53-/- single mutant animals 
ranged from 0.05% to 0.19%, indicating that no substantial clonal expansion 
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had occurred by this stage (Figure 2). In contrast, the thymus of double 
mutant animals already contained several expanded clones by three weeks 
pp, with 4 or 5 distinct clones each comprising >1% of total sequence reads, 
and at least one clone accounting for >20% of TCRβ rearrangements 
detected (Figure 2). Clonal expansion in P53-/- single mutant animals is first 
detectable at nine weeks pp (Dudgeon et al. 2014); hence, Caph2 mutation 
greatly accelerates the outgrowth of clonal T cell populations in the thymus of 
juvenile P53-/- animals.  
An aging cohort of 14 double mutants all became terminally ill within 
100 days (median survival = 81 days, Figure 1C), with massive thymic 
lymphoma apparent in every case. This represents a substantially reduced 
survival relative to either mutation alone (median 447 days for Caph2nes/nes, 
144 days for P53-/- (Figure 1C), Log-rank p < 0.001 for both comparisons). No 
evidence of non-lymphoid tumours was observed upon necropsy of double 
mutant animals. 
 
Abnormal metaphase chromosome structure and anaphase in 
Caph2nes/nes thymocytes 
It has previously been reported that thymic T cell development is impaired 
during the DN to DP transition in young adult Caph2nes/nes individuals (Gosling 
et al. 2007), which is also the stage during which our data reveal that 
lymphomas arise in aged animals (Figure 1D). The cellular defects that block 
T cell development in Caph2nes/nes animals are known to be T cell autonomous 
and independent of VDJ recombination (Gosling et al. 2007), but it is not 
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known whether they affect mitosis, or possible alternative functions of 
condensin II during interphase (Gosling et al. 2007; Rawlings et al. 2010; 
Wood et al. 2010).  
Although we found that interphase cells at the DP stage were 
increased in size in Caph2nes/nes animals, this was attributable to increased 
ploidy, rather than interphase chromosome decompaction, because no 
difference in size was apparent between wildtype and mutant cells of 
equivalent DNA content (Figure S2A). No evidence for localised chromatin 
decondensation was observed in analyses of mean squared distances (d2) 
between FISH probes (Eskeland et al. 2010) separated by 0.1Mb at the non-
expressed HoxA locus (Figure S2B), or by 0.1Mb, 1Mb and 5Mb at the 
expressed CD8 locus (Figure S2C) in DP CD71+ Caph2nes/nes cells. Radial 
positioning (Figure S2D), and chromocenter clustering (JW, unpublished data) 
were also not significantly affected by Caph2 mutation. 
Expression microarray comparisons between DP thymocyte subsets 
from Caph2+/+ and Caph2nes/nes animals revealed only subtle effects on the 
transcriptome (R2 = 0.99), as expected for comparisons between carefully 
stage-matched cell populations (Figure S3A). However, gene ontology 
enrichment analysis performed on gene lists ranked by fold change revealed 
functional classifiers that were strongly enriched among genes upregulated in 
Caph2nes/nes cells (Figure S3). In both the rapidly cycling CD71+ and the 
quiescent CD71- DP population, the most significantly enriched terms centred 
on metabolism and proteostasis (Figure S3B, Figure S3C, Table S1 & S2). 
Each of these processes has recently been implicated in the cellular stress 
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response to aneuploidy (Williams et al. 2008; Torres et al. 2007; Sheltzer et 
al. 2012). Thus, although a tumour-causing mutation in Caph2 influences the 
size and transcriptional profile of pre-malignant cells, both differences are 
consistent with perturbation of the mitotic cell cycle. However, more subtle 
direct effects on interphase chromosome structure cannot be excluded. 
We next sought evidence of abnormal cell cycle progression in 
premalignant Caph2nes/nes cells from the relevant developmental stage. DN 
thymocytes were purified from young adults, before tumour onset, by 
fluorescence activated cell sorting (FACS) and cultured on monolayers of 
OP9-DL1 stromal cells (de Pooter and Zúñiga-Pflücker 2007), where they 
undergo extensive proliferation and differentiate into DP cells. Caph2nes/nes 
thymocytes showed impaired proliferation and differentiation in this ex vivo 
system (Figure S4A, S4B), validating its utility for mechanistic studies.  
To address whether mitotic entry was delayed in primary Caph2nes/nes 
thymocytes, we used a BrdU chase assay to follow the kinetics of progression 
from S phase into M phase (Figure 3A). BrdU and nocodazole were added 
simultaneously to day 5 OP9/DL1 cultures, in order to label cells in S phase, 
and to arrest cells in prometaphase, respectively. Over a four hour time 
course, we then used flow cytometry to measure the fraction of BrdU labelled 
cells in mitosis, based on expression of the mitotic marker histone H3 
phosphorylated at serine 10 (pH3S10). Caph2 mutation did not affect the rate 
at which BrdU labelled cells accumulated in mitosis (two-tailed t-test p > 0.1 
for all time points).  
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To determine whether cell cycle progression was impaired after mitotic 
entry, immunofluorescence was performed on thymocytes grown on OP9-DL1 
co-cultures in the absence of nocodazole, using antibodies against alpha-
tubulin and pH3S10, and the proportion of pH3S10+ cells at different stages of 
mitosis was assessed. Cells at later stages (late anaphase & telophase) were 
significantly underrepresented relative to earlier stages in the Caph2nes/nes 
mutant cultures (Fisher’s exact p < 0.003, Figure 3C), indicating a cell cycle 
block that impaired progression into successful anaphase. To enrich for 
anaphase cells, primary Caph2nes/nes thymocytes from OP9/DL1 co-cultures 
were released into anaphase following wash-out of the proteasome inhibitor 
MG132. Immunofluorescence revealed an elevated frequency of 
abnormalities (Fisher’s exact p < 0.0001), primarily comprising anaphase 
bridges plus occasional lagging chromosomes, multipolar spindles and 
micronuclei (Figure 3D & 3E). These mitotic abnormalities are likely to 
originate from defective mitotic chromosome structure, because metaphase 
chromosomes showed a characteristic “zig-zag” appearance following 
hypotonic treatment (Figure 3F), similar to previous reports of condensin II 
deficiency in immortalised vertebrate cells (Ono et al. 2003; Green et al. 
2012). Abnormal mitosis had a profound effect on the ploidy of proliferating 
DP thymocytes, with an accumulation of cells with a DNA content of 4N or 
greater (Figure S4C). Importantly, T cells with abnormal ploidy were already 
abundant in neonatal Caph2nes/nes mice (Figure S4C), substantially before 
clonal expansion is first detectable (Figure 2). The profound mitotic 
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abnormalities evident in Caph2nes/nes T cells therefore precede malignant 
transformation, and cannot be a downstream consequence. 
Given that mitosis is thought to be a cell-type invariant process, we 
next sought to determine whether ploidy is perturbed to a similar extent in all 
cell types of Caph2nes/nes mice. Multiparametric flow cytometry was used to 
compare cellular DNA content as haematopoietic stem and early progenitor 
cells from Caph2nes/nes and control animals differentiate into αβ-T and B 
lymphocytes in vivo (Figure 4, Figure S5, Figure S6). This revealed that ploidy 
was largely unaffected by Caph2 mutation in bone marrow progenitor 
populations, B cells and early thymic T cell subsets, with abnormalities 
becoming evident only from the β-selection stage of T cell development 
onwards (Figure 4, Figure S5). This cell-type-specific phenotype was not 
simply attributable to a greater proportion of proliferating cells, because BrdU 
incorporation was detected in a comparable percentage of DP CD71+ T cells 
(61% - Figure S5H) and B cells at the Fraction C stage (59% - Figure S5D) in 
wildtype mice, yet abnormal ploidy in Caph2 mutants was restricted to T cells 
(Figure 4).  
Together, these data demonstrate that germline hypomorphic mutation 
in Caph2 impairs cell cycle progression at a specific stage of αβ-T cell 
development; CD4+CD8+ thymocytes enter mitosis with normal kinetics but 
abnormal chromosome structure, which leads to anaphase bridges and 
impaired mitotic progression in pre-malignant cells, preceding tumour 
initiation. Moreover, our studies of haematopoietic differentiation demonstrate 
that the same mutation in condensin II can elicit different effects on 
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chromosome segregation in different proliferative cell types, which suggests 
that the formation of segregation-competent mitotic chromosomes is a 
developmentally regulated process. 
 
Exit from Caph2 deficient mitosis leads to DNA damage, tetraploidy, and 
P53 activation 
Using imaging flow cytometry, we next assessed the incidence of DNA 
damage in primary thymocytes at different phases of the cell cycle by the 
simultaneous quantification of γH2AX foci, BrdU incorporation and DNA 
content (Figure 5A - C). In the smallest 25% of cells with 2N DNA content, 
which includes cells that have recently completed mitosis, γH2AX foci 
occurred in 85% of Caph2nes/nes, compared to just 2% of wildtype cells (Figure 
S7). The average number of discrete γH2AX foci per nucleus was also 
significantly increased by Caph2 mutation (Figure 5C, Figure S7B). However, 
elevated frequencies of cells with γH2AX foci were also observed in S and G2 
phase (Figure 5B), which could be explained by defective DNA repair or the 
ongoing acquisition of damage during S phase. 
 In addition to diploid cells with DNA damage, we found an abundance 
of abnormally large DP cells that had undergone cell cycle arrest (Figure 6A 
and 6B). Quantification of DNA content in this population revealed that they 
were 4N (Figure 6C), suggesting arrest during either G2, or in a tetraploid G1 
phase. However, given that Caph2nes/nes thymocytes progress from S phase to 
M phase with normal kinetics (Figure 3B), we hypothesised that a tetraploid 
G1 was the more likely scenario. To confirm this, we assessed sister 
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chromatid cohesion in FACS-purified 4N cells using fluorescence in situ 
hybridisation (FISH) experiments that combined fosmid probes and 
chromosome paints (Figure 6D). This revealed that, contrary to the 
expectation for a G2 cell, the four chromosomal homologs were typically not 
subject to sister chromatid cohesion (Figure 6D). We therefore conclude that 
these arrested 4N cells, which make up at least 20% of all CD4+CD8+ cells in 
the Caph2nes/nes thymus (Figure 6A & B), are arrested in a tetraploid cell cycle 
phase resembling G1, presumably following mitotic exit without completing 
chromosome segregation and cytokinesis. 
 P53-dependent checkpoints ordinarily limit the proliferation of cells 
with DNA damage (Kastan et al. 1991; Lowe et al. 1993) and abnormal ploidy 
(Fujiwara et al. 2005; Thompson and Compton 2010), and play a key role in 
suppressing lymphomagenesis in both wildtype (Donehower et al. 1992) and 
Caph2nes/nes animals (Figure 1C, Figure 2). To interrogate the signalling 
pathways operating downstream from P53 in Caph2nes/nes thymocytes, we 
assessed the expression of 84 known P53 targets by qRT-PCR in non-cycling 
(CD71-) DP cell populations isolated from young animals, prior to tumour 
establishment. Key regulators of apoptosis (Noxa, Fas) and cell cycle arrest 
(Cdkn1a) were upregulated by >2.5-fold in Caph2nes/nes thymocytes in a P53-
dependent manner (Figure S8A, Table S3). Notably, we found that the 
upregulation of P53 targets occurred in cells with 2N, as well as 4N DNA 
content (Figure S8B), demonstrating that P53 signalling is activated 
regardless of whether cells exit mitosis in a diploid or tetraploid state.  
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P53 status determines copy number changes in Caph2 mutant tumours 
To characterise genomic changes which accompany lymphomagenesis in 
Caph2 mutant T cells, we performed shallow whole genome sequencing 
(Scheinin et al. 2014) of genomic DNA extracted from terminal tumours of 
animals with germline mutation in Caph2 and P53 (Figure 7, Figure S9). 
Whole chromosome aneuploidy (WCA) was rare in terminal tumours from 
Caph2nes/nes single mutants (n = 7 tumours, mean WCA = 1.4, median WCA = 
1)(Figure 7B). Absolute copy number enumeration of selected loci by FISH 
(Figure S10) confirmed that Caph2nes/nes single mutant tumours were near 
diploid rather than tetraploid. Although deletions spanning the P53 locus were 
not apparent in Caph2nes/nes single mutant lymphomas, several top scoring 
deletions encompassed key P53 pathway components such as Cdkn2a and 
Pten, and other known suppressors of human T cell malignancy such as 
Bcl11b (Gutierrez et al. 2011) (Table S4). Thus, despite the abundance of 
tetraploid cells in the premalignant DP population (Figure 4, Figure 6, Figure 
S4C), these data argue that tumours from Caph2nes/nes; P53+/+ mice initiate 
from cells that acquire DNA damage and mutation without undergoing 
genome doubling (Figure 5, Figure S7). 
Tumours from double mutant animals contained significantly more 
whole chromosome aneuploidies than Caph2nes/nes single mutants (n = 13 
tumours, mean WCA = 7.3, median WCA = 6, two-tailed t-test p < 0.001) 
(Figure 7B & Figure S9). Double mutant tumours also contained, on average, 
two to three-fold more segmental copy number aberrations (CNAs) compared 
to Caph2 single mutant tumours, and over twenty-five-fold more than tail DNA 
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(Figure 7C & D). Recurrently amplified regions contained known oncogenic 
drivers of human T cell lymphoma, including Notch (12 of 13 tumours) and 
Ptpn14 (11 of 13 tumours). We conclude that the large population of cells with 
abnormal ploidy, that is present in the Caph2nes/nes thymus before clonal 
expansion, has the potential to form highly aggressive tumours but is 
ordinarily prevented from doing so by a P53-dependent mechanism.  
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Discussion 
In this report we provide experimental support for the hypothesis that 
condensin dysfunction can promote tumourigenesis (Hirano 2012; Longworth 
et al. 2008; Manning et al. 2010; Coschi et al. 2010; 2014; Ham et al. 2007). 
We found that tumours initiate from thymic T cells progressing from the DN to 
DP stage, which allowed us to characterise the cellular abnormalities that 
precede, and therefore presumably drive, Caph2-dependent malignancy. 
Through detailed cytological analysis of tumour initiating cells in the thymus of 
Caph2nes/nes mice, we show that a tumour-causing mutation in Caph2 does not 
promote global decondensation of interphase chromatin (Figure S2), or major 
changes in developmental gene expression programs (Figure S3). However, 
we leave open the possibility that the Caph2nes mutation impairs interphase 
processes in a manner that was not detected in our study.  
Abundant evidence was obtained for a direct effect of the Caph2nes 
mutation on mitosis. Tumour-initiating cells at the DP 71+ stage of T cell 
differentiation show impaired mitotic progression, but not mitotic entry (Figure 
3), and generate two distinctly abnormal cell populations upon mitotic exit. 
Diploid cells show extensive DNA damage (Figure 5, Figure S7), and we 
propose that when such damage yields mutations in tumour suppressor 
genes such as Cdkn2a, Pten or Bcl11b (Table S4), this population can give 
rise to the near diploid lymphomas observed in aging Caph2nes/nes animals 
(Figure 7A, Figure S9, Figure S10). In addition, a large fraction (>20%) of all 
DP thymocytes in young Caph2 mutants exit mitosis in a tetraploid state 
(Figure 6B & 6C). 
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The fact that tumours in Caph2nes/nes animals with an intact P53 
pathway do not show frequent whole chromosome gains argues that 
tetraploidy does not promote malignancy in the presence of P53, consistent 
with previous reports (Fujiwara et al. 2005). Under these circumstances, we 
speculate that mitotic exit in the tetraploid state may be a more favourable 
outcome for cells with persistent catenations than completion of chromosome 
segregation with DNA damage, because the latter has greater potential to 
generate oncogenic mutations.  
Disease progression is markedly accelerated when the P53 pathway is 
disabled (Figure 1C), where abnormal clonal outgrowth is readily detectable 
by deep sequencing of the TCRβ repertoire during the first three weeks of life 
(Figure 2). In a Caph2nes/nes P53-/- background, dominant clones exhibit 
multiple whole chromosome gains (Figure 7A, Figure S9D) or evidence of 
genome doubling (Figure S9D). The high fraction of viable tetraploid cells that 
arise spontaneously in the Caph2nes/nes thymus (Figure 6), combined with the 
rapid and highly reproducible course of disease progression in Caph2nes/nes 
P53-/- animals (Figure 1C, Figure 2), provides an attractive model for future 
studies on the pathological consequences of genome doubling in vivo.  
In a companion paper we describe a cohort of four human patients with 
germline condensin mutations that result in microcephalic primordial dwarfism 
(Martin et al, accepted at Genes & Development). One of these patients died 
from malignant anaplastic medulloblastoma at the age of 11, which suggests 
that germline condensin deficiency may increase the risk of tumourigenesis in 
humans. Somatic condensin mutations occur in a small but statistically 
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significant fraction of human cancers (4.2% (Leiserson et al. 2014)), and a 
large majority of condensin mutations in the COSMIC database 
(http://cancer.sanger.ac.uk/cosmic) are missense substitutions analogous to 
Caph2nes (Figure 1B, Figure S1A). However, genomic analyses of human T 
cell leukemias and lymphomas (Zhang et al. 2012; Kataoka et al. 2015) 
indicate that condensin mutations are no more frequent than in other tumour 
types, suggesting that the strong tissue-selectivity reported here is likely to be 
species-specific. The reasons that murine T cell development is uniquely 
vulnerable to global condensin II mutation are likely to be multifaceted, but 
could involve kinetic properties of the cell cycle, or stress responses arising 
from aberrant mitosis that distinguish the highly proliferative cells at the DN to 
DP transition from other somatic cell types. 
Several recent reports have provided evidence that condensin II 
function could be impaired in human tumours via a more widespread 
mechanism that does not require mutations in the core complex (Longworth et 
al. 2008; Manning et al. 2010; Coschi et al. 2010; 2014). Mutations in the Rb 
tumour suppressor, which is among the most frequently mutated genes in a 
broad range of human tumours, partially impair condensin II loading and 
function (Longworth et al. 2008; Manning et al. 2010; Coschi et al. 2010; 
2014). This provides a possible explanation for the high levels of 
chromosomal instability reported in Rb1-deficient tumours, and, together with 
the data reported here, suggests that the clinical relevance of this alternative 
Rb1 function should be carefully evaluated. 
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Materials & Methods 
 
Animals and primary cell isolation 
The animal studies described in this paper were carried out under the 
guidance issued by the Medical Research Council in Responsibility in the Use 
of Animals for Medical Research (July 1993) and Home Office Project Licence 
no PPL60/4424. Animals were housed in individually ventilated cages within 
the Biomedical Research Facility at the Western General Hospital, Edinburgh. 
Tumour samples from P53-/- tumours used for copy number analysis were 
from animals housed in the BSU facilities at the CRUK Beatson Institute 
under project license PPL60/4181. The Caph2nes (Gosling et al. 2007; Nelms 
and Goodnow 2001) and P53- (Jacks et al. 1994) mutations were generated 
as described previously, and maintained on a C57BL6/J background. Unless 
otherwise stated, non-tumour tissues were harvested from 6 – 12 week 
animals and processed immediately. No differences in T cell phenotype were 
observed between male and female mice; hence, animals of either gender 
were used interchangeably. Female mice were used for all aging studies, with 
the exception of the Caph2nes/nes P53-/- genotype, for which males were used 
due to a low frequency of female mice recovered.  
Single cell suspensions were obtained from thymus by gentle tissue 
dissociation through a 40 micron filter, and from femur and tibia by flushing 
bone cavities with PBS (B cells), or by crushing bones with a pestle and 
mortar (LSK and CLP populations). Tissues were collected and processed 
immediately following termination, and cell counts were conducted on a moxi-
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Z automated cell counter (ORFLO). For BrdU incorporation studies 150 μl of 
10mg/ml BrdU solution was injected into the intraperitoneal cavity two hours 
prior to termination.  
 
Cell culture 
For primary T cell cultures, CD4+ and CD8+ thymocytes were depleted using 
MACS beads (Miltenyi) according to manufacturer’s instructions. For the 
proliferation and differentiation assays shown in Figure S4 and the mitotic 
studies shown in Figure 3, DN3 cells were then purified by FACS using 
surface expression of CD25 and CD44. For the BrdU chase experiment in 
Figure 3A & B, total DN cells were seeded, whereas for all other OP9/DL1 
experiments of mitosis and cell cycle progression, DN3 cells were seeded 
directly following FACS purification. Details of cell surface marker 
combinations used for immunophenotyping are listed in Table S5. 1 – 5 x 105 
total DN cells or 2.5 x 104 DN3 cells were seeded onto each well of a 6 well 
plate, containing subconfluent monolayers of OP9-DL1 stromal cells in α-
MEM medium (+nucleosides) supplemented with 20% Fetal Bovine Serum, 
1% Pen/Strep, 15μM β-Mercaptoethanol and 1ng/ml IL-7 (Peprotech). Cell 
cycle studies were conducted 4 or 5 days after seeding total DN cells, when 
lymphocytes were removed from monolayers by gentle pipetting, then passed 
through a 40uM filter to remove clumps of stromal cells before further 
processing. For BrdU chase experiments, BrdU (10μM final concentration) 
and nocodazole (300ng/ml) were added to cultures on day 4 or 5, then cells 
were collected at the specified time points before staining for cell surface 
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markers, pH3S10 and BrdU using the APC BrdU Flow kit (BD Pharmingen), 
according to manufacturers instructions, with pH3S10 antibody added at the 
same time as anti-BrdU.  
 
Immunofluorescence 
Cells from OP9-DL1 co-cultures were washed once with PBS and allowed to 
settle on poly-lysine-coated coverslips before. For MG132 release, MG132 
(Cayman) was added to day 4 OP9/DL1 co-cultures to a final concentration of 
15μM. After two hours, T cells were removed by gentle pipetting, washed 
once with PBS and seeded on fresh OP9-DL1 monolayers in media lacking 
MG132. After 60 minutes, T cells were removed by gentle pipetting and 
allowed to settle on poly-lysine-coated coverslips. Cells were fixed in 4% 
paraformaldehyde for 10 mins, washed 3 x 5 minutes in PBS (hereafter 
“washed”), permeabilised in 0.5% TritonX in PBS for 10 minutes, washed, 
blocked in goat or donkey serum (5% in PBS) for 30 minutes, incubated with 
primary antibodies at 4°C overnight, washed, incubated with secondary 
antibodies for 1 hour at room temperature, washed, incubated in 0.5μg/ml 
DAPI for 5 minutes and then mounted in vectashield (vector labs). Antibodies 
used in this study are listed in Table S6.  
 
Metaphase spreads 
To generate metaphase spreads, cells were treated with hypotonic solution 
(0.5% sodium citrate, 0.25% potassium chloride in deionised water) and fixed 
in 3:1 methanol: acetic acid, added drop-wise whilst vortexing the sample. 
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The samples were incubated at room temperature for 30 minutes, before 
centrifugation, re-suspension in 10mL fix, and overnight storage at -20oC. The 
cell suspension was dropped on to high precision cover-glass (Marienfelt, 
Germany), stained with DAPI (50ng/ml in PBS) and mounted in Prolong Gold 
(Life Technologies). 3D SIM images were acquired on a N-SIM (Nikon 
Instruments, UK) using a 100x 1.49NA lens and refractive index matched 
immersion oil (Nikon Instruments). SIM images were reconstructed using NiS 
Elements software (Nikon Instruments) from a z stack comprised of no less 
than 1um of optical sections. 
 
FISH probe synthesis, hybridisation and image analysis 
To prepare nuclei for three dimensional FISH, cells were allowed to settle on 
poly-lysine-coated slides then fixed in 4% PFA for 10 minutes at 37°C, 
washed, permeablised in 0.5% Triton X in PBS for 10 minutes, washed, and 
then left to dehydrate at room temperature, before being stored at -80oC for 
up to 2 months. Upon thawing, slides were rinsed in 2xSSC then incubated in 
2xSSC containing 100 μg /mL RNase (Roche) at 37°C for 1 hour. Slides were 
washed in 2xSSC and then dehydrated through a series of two minute ethanol 
washes (70%, (90% and 100%) before being air dried. Slides were then 
heated in a 70°C oven for five minutes and denatured for 30 minutes at 80°C 
in 70% formamide/2xSSC, pH7.5. The slides were transferred to ice-cold 70% 
EtOH for two minutes, before further dehydration in 90% and 100% ethanol at 
room temperature, for two minutes each. 
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With the exception of the experiment presented in Figure 5 (see below), all 
FISH probes were generated from fosmids (details in Table S7). To prepare 
fosmid probes, DNA was isolated using standard alkaline lysis and labelled by 
nick-translation with digoxigenin-11-dUTP or biotin-16-dUTP (Roche). 
Approximately 70 - 100ng of fosmid was used per slide, together with 18ug 
mouse Cot1 (Invitrogen) DNA and 5ug of salmon sperm DNA (Sigma). 
Ethanol precipitated DNA was resuspended in 15uL hybridisation mix (50% 
deionised formamide, 10% dextran sulphate and 1% Tween 200 in 2xSSC). 
Probes were denatured at 70°C for five minutes and then reannealed at 37°C 
before being applied to the slide and sealed under a coverslip at 37°C. After 
48 hours, coverslips were removed and slides underwent 4 x 2 minute 
washes in 2X SSC at 45°C, then 4 x 3 minute washes in 0.1X SSC at 60°C. 
Slides were then transferred to 4X SSC/0.1% Tween at room temperature 
before a 5 minute incubation with blocking buffer (4X SSC, 5% Marvel) under 
a coverslip. Biotinylated probes were detected using Texas Red (TR)-
conjugated avidin (1mg/mL stock diluted 1:500 in blocking buffer), followed by 
biotinylated antiavidin (BAA) (0.5mg/μL diluted 1:100) and a final layer of TR-
conjugated avidin (1mg/mL diluted 1:500). Digoxigenin-labeled probes were 
detected with sequential layers of Fluorsecein isothiocyanate (FITC)-
conjugated antidigoxigenin (200μg/mL diluted 1:20) and FITC-conjugated 
anti–sheep (1.5mg/mL diluted 1:100). All antibodies were obtained from 
Vector Laboratories with the exception of FITC-conjugated anti-digoxigenin 
which was obtained from Roche. Antibody incubations were carried out in a 
humid chamber at 37°C for 30-60 minutes, followed by 3 x 2 minute washes in 
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4xSSC/0.1% Tween at 37°C before the addition of the next layer of antibody. 
After the last antibody incubation, slides were incubated in 4X SSC/0.1% 
Tween with 50ng/mL DAPI for 2 minutes before mounting in Vectashield 
(Vector labs). 
For the experiment to assess sister chromatid cohesion presented in Figure 
5D & 5E, both the chromosome 2 exome paint and 130kb HoxD-specific 
probe were generated by direct labelling of liquid-phase oligonucleotide pools 
obtained using sequence capture technology (Boyle et al. 2011). The 
oligonucleotide isolation, labelling and hybridisation steps were performed as 
described previously (Boyle et al. 2011). To assess sister chromatid cohesion, 
we FACS purified 4N cells and counted the number of distinct HoxD signals 
per nucleus. For quantification purposes, only signals separated by >0.5µM 
were counted. Probes generated from oligonucleotide pools (Figure 5D & 5E) 
lack repetitive sequences, and hence false positive signals are greatly 
reduced. 
 
Flow Cytometry, FACS and Imaging Flow Cytometry   
Single cell suspensions were incubated with antibodies against cell surface 
antigens at room temperature for 10 minutes and washed once in PBS prior to 
analysis. The combination of cell surface markers used to identify each cell 
population is listed in Table S5, with antibody details in Table S6.  For DNA 
content analysis, surface stains were fixed using the CytoFix/CytoPerm kit 
(BD) according to manufacturers instructions, before a secondary fixation step 
in cold 70% ethanol for 20 minutes at 4°C, wash in cytoperm buffer (BD 
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Pharmingen) before resuspension in cytoperm buffer containing 10μg/ml 
DAPI. Data were acquired on a BD FACSAria II cell sorter or BD LSRFortessa 
cell analyser, and processed using FlowJo software (Treestar). DNA content 
measurements by flow cytometry are susceptible to artifacts arising from cell 
aggregates. For all conventional flow cytometry experiments, we performed 
strict aggregate exclusion based on area versus height of the DAPI and 
Forward Scatter signals (data not shown). We also validated our finding of 
elevated polyploidy in Caph2nes/nes cells using imaging flow cytometry and 
FISH (data not shown).  
BrdU staining was performed using the APC BrdU Flow kit (BD 
Pharmingen) according to manufacturer’s instructions. For quantification of 
γH2AX positive cells at different cell cycle stages, total thymocytes were 
isolated from the thymus of mice two hours following BrdU injection, and 
stained with anti-BrdU-APC, anti-γH2Ax-FITC and DAPI, using the BrdU Flow 
kit protocol (BD Pharmingen). Fluorescent and brightfield images were 
captured using an ISx MKII (Amnis) using a 60X objective. Following 
acquisition and compensation the data was analysed with IDEAS (Amnis) 
software, using a modified version of published methods (Parris et al. 2015) 
as follows. In addition to the automatically generated system image masks 
three further masks were built. The first mask eroded the DAPI mask by two 
pixels to ensure any perinuclear signal was not included in subsequent 
analysis of nuclear staining patterns and intensities. A second mask was 
generated based on FITC intensity, removing pixels with an intensity of 600 or 
less, to remove background and nonspecific staining, and to ensure only 
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clearly defined intense spots were retained for counting. A third mask used a 
Boolean instruction to combine the two masks described above to ensure that 
only FITC foci localised to the region of the nuclei were counted. A spot count 
feature was generated based on the combined mask. 
A data analysis pathway identified round single cells (RSCs) on the 
basis of size and circularity of the bright field images. Gated RSCs were input 
into a histogram to select cells in focus, based on the intensity of adjacent 
pixels in an image (the Gradient Root Mean Squared function). In focus round 
single cells were then used as the population in a histogram to identify BrdU 
positive and negative cells. 2N, and ≥4N cells were identified from the BrdU 
negative population based on DAPI fluorescence. The three populations were 
plotted by number of γH2AX foci against overall γH2AX staining intensity (e) 
and cells with at least one focus above an intensity threshold categorised as 
γH2AX positive. 
 
T Cell Receptor Sequencing 
DNA was extracted from flash frozen thymus tissue using DNeasy blood and 
tissue kit (Qiagen). The TCRβ locus was sequenced using the ImmunoSeq 
Assay (Adaptive Biotechnologies) at survey level resolution, using 0.8 – 1μg 
of starting material. PCR amplicons spanning the variable to constant sections 
of the TCRβ chain were sequenced using the illumina MiSeq platform, and 
potential PCR biases were controlled using algorithms provided by Adaptive 
Biotechnologies (Carlson et al. 2013). Data were analysed using the 
ImmunoSeq data analysis portal on the Adaptive Biotechnologies website. 
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The two samples from P53-/- single mutants were from a published study 
(Dudgeon et al. 2014), for which the data were available through the 
Immunoseq portal for analysis alongside the data generated for this study. 
 
Copy Number Data Generation 
Genomic DNA was isolated from FFPE tumour samples using the BioStic 
FFPE kit from Mo Bio laboratories, and from flash frozen tumour samples 
using the DNAeasy kit from Qiagen. Copy number analysis was performed as 
previously described (Scheinin et al. 2014). In brief, DNA was sheared with a 
Covaris S2 (Covaris) followed by the TruSeq NANO kit V2 (Illumina). Final 
sequence library amplification was performed with 10 PCR cycles for the 
FFPE-derived DNA samples and 8 PCR cycles for DNA derived from fresh 
samples. The yield of the sequence library was assessed with a DNA 7500 
chip on a 2100 BioAnalyzer (Agilent Technologies). A double-sided bead size 
selection procedure with Agencourt AMPure XP beads (Beckman Coultier) 
was performed to clean the DNA preparations. The barcoded mouse samples 
were equimolarly pooled, and 12.5 pM molarity with 1% phiX was loaded on a 
HiSeq Single End Flowcell (Illumina). This was followed by cluster generation 
on a cBot (Illumina) and sequencing on a HiSeq 2500 (Illumina) in a single-
read 50-cycle run mode (SR50-HTV4). BAM files have been submitted to the 
Sequence Read Archive (NCBI) under experiment ID SRX1391296. (final 
accession pending curation of data) 
 
Copy Number Data Analysis 
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The mouse reference version GRCm38/mm10 was used to determine GC 
content and mappability. GC content was calculated for 30kpb and 1Mb bin 
sizes and mappability was determined with GEM-mappability (Derrien et al. 
2012) allowing two mismatches. Loess residuals, used to make a mouse 
C57BL/6J specific blacklist, were calculated with 24 samples obtained from a 
publicly available normal mouse C57BL/6J data set (Gnerre et al. 2011). Only 
the first 50bp of the forward read were included for residual calculation. In 
addition, the 50bp reads of the 3 normal mouse C57BL/6J samples, 
sequenced in parallel with the tumors, were included in the residual 
calculations. The data was analysed with QDNAseq version 1.4.2 (Scheinin et 
al. 2014). Copy number profiles were segmented with DNAcopy (Venkatraman 
and Olshen 2007) and copy number aberrations were called by selecting 
segments with a log2-ratio higher than 0.20 or lower than -0.23, 
corresponding to a single gain or a single loss in 30% of the analysed cells 
(van Thuijl et al. 2014). Breakpoints were defined at the junction between bins 
of different copy number according to the criteria above. For the deletion list in 
Table S4, we started with all regions of copy number loss in Caph2nes/nes 
single mutant tumour samples, and removed regions corresponding to the X 
chromosome and T Cell Receptor loci, in addition to regions also deleted in 
Caph2nes/nes tail DNA. The remaining regions were ranked according to log2 
ratio, and the top ten ranking regions were manually curated to identify tumour 
suppressor genes. 
 
Homology detection and structural interpretation of mutation 
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The mouse Caph2 sequence was used to search for homologous structures 
using the HHPred  server(Söding et al. 2005). Three bacterial condensin 
structure hits (PDB IDs: 4I98_A; 3ZGX_C; 3W6J_A) were returned with their 
corresponding alignment that includes the first two alpha-helices. Additional 
Caph2 vertebrate orthologues were detected with a BLAST search against the 
SwissProt database at the NPS@ server(Combet 2000), and included into the 
multiple sequence alignment with minor manual editing. Figure 1B was 
prepared using ESPript version 3(Gouet et al. 2003). Intra-protein interactions 
for the I15N equivalent residue in B.subtilis (I22) were analysed using the 
Protein Interactions Calculator (PIC)(Tina et al. 2007) using a 5 Å sphere 
radius cut-off. Residue-specific solvent accessibility calculations were 
performed using ASAView(Ahmad et al. 2004). Structure visualisation and 
analysis, and the preparation of Figure 1B, was conducted using PyMOL 
(http://www.pymol.org/; Schrödinger LLC, USA).  
 
Transcriptome Analysis 
Total RNA was extracted using TRIzol reagent (Life technologies), and RNA 
quality was assessed using Bioanalyzer (Agilent). From each of three 
biological replicates per sample (cell purification scheme detailed in Figure 
S3A), 80ng RNA was amplified and biotinylated using the MessageAmp II kit 
(Ambion). 750ng cRNA was hybridised to Mouse Ref-8 v2 Expression 
Beadchips (Illumina) using Whole-Genome Expression Direct Hybridisation kit 
(Illumina) and scanned with a Highscan (Illumina). Raw data were analysed 
using Bioconductor within the FlexArray software package 
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(http://genomequebec.mcgill.ca/FlexArray). RMA background adjustment, 
variance stabilisation transformation (VST) and robust spline normalisation 
were applied. Mean signal values were calculated at the gene level using 
ANOVA, and tests for difference between sample types were conducted using 
equal variance t-tests. Using conventional cutoffs for statistical significance 
(>2-fold change, p <0.05), very few transcripts were returned as differentially 
expressed between stage-matched DP thymocyte populations. To identify 
more subtle trends, all genes on the array with associated Ensembl and gene 
symbol annotations were first ranked according to fold change (Caph2nes/nes / 
Caph2+/+), and the ranked list was used as the input for gene ontology term 
enrichment within the “Process” classification using the GOrilla tool (2009). 
Full lists of terms returned by the GOrilla tool are listed in Tables S1, S2 and 
S8. MIAME-compliant microarray data are available under GEO accession 
GSE65199. 
 
qRT-PCR 
For the qPCR array experiments depicted in Figure S8A and Table S3, DP 
CD71- cells were purified from thymocytes that were first enriched for CD4+ 
cells by MACS (miltenyi), then FACS purified for CD4+, CD8+ and CD71+ using 
the scheme outlined in Figure S4C. Cell purity was typically 85 – 95%. Total 
RNA was extracted from cells using TRIzol reagent (Life technologies), 
followed by purification through an RNAeasy colum (Qiagen). RNA quality 
was assessed using Bioanalyzer (Agilent). From each of two biological 
replicates per sample, 100ng RNA was reverse transcribed using the RT2 
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first-strand kit (Qiagen). qRT-PCR was performed on technical 
#quadruplicates using the mouse P53 pathway qRT-PCR array (Qiagen: 
PAMM-027Z). Normalisation and all downstream analysis steps were 
performed according to the manufacturer’s instructions, and data analysis was 
conducted using the RT2 profiler PCR-array software (Qiagen). For the 
experiment in Figure S6B, total thymocytes were incubated with Hoechst for 
30 minutes in Hanks balanced salts solution, then sorted according to DNA 
content and processed as above using primers designed in house. All qRT-
PCR data in Figure S6A, S6B and Table S3 represent mean values from two 
biological replicate experiments, each comprising two technical replicate 
PCRs. 
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Figure Legends 
Figure 1: Missense mutations in Caph2 induce thymic lymphoma 
A. Schematic of the condensin II complex (Bürmann et al. 2013; Piazza et al. 
2014). The box indicates the region which is expanded in panel B. B. (right) 3-
D structure of the Smc head domain (SmcHead) and ScpA N-terminal domain 
(ScpAN) from B. subtilis (PDB ID: 3ZGX)(Bürmann et al. 2013) is shown using 
PyMOL. The two non-contiguous sequence regions that together form the 
Smc ATPase head domain are colour coded in orange (SmcHeadN) and green 
(SmcHeadC), respectively, while the ScpAN domain fragment is shown in pink. 
(left) The side-chain of the I15 equivalent residue in B. subtilis ScpA (I22), and 
its interacting residues, is depicted in sphere representation. Note that 
residues Y44 and M48 form part of the second α-helix, which makes direct 
contact with the SMC coiled-coil. C. Kaplan-Meier plot showing survival of 
Caph2nes/nes and P53-/- mutant animals. The study was terminated at 15 
months and surviving animals were examined for tumours during necropsy. D. 
Flow cytometry (FC) dot plots show the distribution of thymic T cell subsets 
according to CD4 and CD8 expression in tissue from young adult mice 
(±SEM, n = 5), and in representative terminal thymic lymphomas. 
 
Figure 2: Caph2 mutation accelerates T cell clonal outgrowth in a P53-
dependent manner 
Pie charts show the frequency of the 5 most abundant T Cell Receptor β 
(TCRβ) clones (grey segments) in the thymus of animals of different 
genotypes at 3 weeks post partum, relative to the remainder of clones 
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detected in each sample (white segment). The percentage of the top 2 clones 
in each sample is listed to the right of each chart. Data for P53 single mutant 
animals was published previously (Dudgeon et al. 2014), and was reanalysed 
through the ImmunoSeq Analyser portal on the Adaptive Biotechnologies 
website. 
 
Figure 3: Tumour-causing Caph2 mutations impair mitotic progression 
A. Overview of the BrdU chase experiment to assess the progression of 
primary CD4+CD8+ thymocytes from S phase into M phase. B. Line graph 
showing the accumulation of BrdU+ cells in M phase (pH3S10+) over a four 
hour time course, as described in panel A. Error bars show SEM of 2 
biological replicates, and are representative of two independent experiments. 
C. Mitotic phase distribution of unsynchronised H3S10P+ thymocytes from 
wildtype (blue) and Caph2nes/nes (red) OP9-DL1 co-cultures stained with anti-
H3S10P, anti-α-tubulin, and DAPI. Cells staining positive for the mitotic 
marker H3S10P were visually assigned to one of three mitotic phase 
categories. Data were pooled from two biological replicate experiments (n = 
59 mitotic cells for Caph2+/+ and 111 for Caph2nes/nes. * two-tailed Fisher’s 
exact p < 0.003 D. Examples of anaphase/telophase cells following MG132 
washout in Caph2nes/nes OP9/DL1 co-cultures, co-stained for α-tubulin (green), 
H3S10P (red) and DAPI (blue). For clarity, tubulin staining is shown only in 
the multipolar spindle image. Scale bars = 3μM. E. % normal and abnormal 
anaphase/telophase T cells from OP9/DL1 co-cultures 1 hour following 
MG132 washout for wild-type and Caph2 mutant. Data represent one 
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experiment F. Structured Illumination Microscopy (SIM) images of DAPI-
stained metaphase chromosomes from wildtype (top) and Caph2nes/nes 
(bottom) cells. Images are representative of >30 metaphase spreads from 
three independent experiments.   
 
Figure 4: Mitotic perturbation arises specifically in the tumour-initiating 
cell population  
Flow cytometry histograms show cellular DNA content profiles during 
differentiation of T and B lymphocytes from multipotent progenitors in vivo. 
Tissues were harvested at 6 - 8 weeks, before tumours are first detected. The 
tumour initiating cell population (DP CD71+) is highlighted with a red box. 
Gates represent the 4N and >4N populations, which are quantified here for 
the tumour-initiating cell population and for all B and T cell subsets in Figure 
S5. B cells subsets were classified into Hardy Fractions A-F (Hardy et al. 
1991). Gating schemes used to identify each population are shown in Figure 
S6, and cell surface markers and antibodies are listed in Table S5 and Table 
S6, respectively. Each histogram represents at least 2000 cells, and is 
representative of three biological replicates for progenitor subsets, and five 
biological replicates for T cell and B cell subsets.  
 
Figure 5: Widespread DNA damage in Caph2 mutant thymocytes 
A. Multispectral images showing representative thymocytes from different cell 
cycle stages, classified based on DNA content and BrdU incoroporation. 
Images were acquired on an ImageStream Flow Cytometer using a 60X 
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objective. B. Histogram showing the percentage of cells with at least one 
bright γH2AX focus at different cell cycle stages. C. Histogram showing the 
frequency of γH2AX foci per nucleus across all cell cycle stages. For panels B 
& C, error bars show SEM of n = 3 biological replicate experiments, each 
comprising 10,000 cells per sample. 
 
Figure 6: Genome doubling causes cell cycle exit in Caph2 mutant 
thymocytes 
A. FC contour plots, gated on CD4+CD8+ thymocytes from 6 - 12 week 
animals, showing a substantial increase in the proportion of abnormally large 
(FSChi) non-proliferating (BrdU-) cells in Caph2nes/nes animals. Percentages 
represent mean values from three biological replicates. B. Contour plots 
presented as in panel A, with proliferation status measured by cell surface 
expression of CD71. Gates that define populations 1 – 4 in panel C are shown 
in red. Percentages represent mean values from three biological replicates. C. 
DNA content of populations 1 - 4 from panel B, determined by FC 
quantification of DAPI fluorescence. The non-cycling population that is greatly 
expanded in the Caph2nes/nes mutant thymus (FSChiCD71lo) is exclusively 4N. 
Data are representative of five biological replicates. D. FISH analysis of 
FACS-purified non-proliferating large thymocytes (populations 2 and 4 in 
panel B), using a chromosome 2 (Chr2) exome paint (red), and a probe 
(green) corresponding to the HoxD locus (HoxD) on Chr2 (top). Two paired 
fosmid signals per nucleus are visible in population 2, whereas population 4 
has four individual signals per nucleus indicating absence of sister chromatid 
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cohesion. Quantification of spatially separated (>0.5μM) HoxD signals is 
depicted in the histogram (bottom). Data are pooled from 2 biological 
replicates (Caph2+/+ n = 81, Caph2nes/nes n = 68). 
  
Figure 7: P53 status determines the frequency of whole chromosome 
and segmental aneuploidy in Caph2 mutant tumours  
A. Example Copy Number Aberration (CNA) plots showing read depth from 
shallow whole genome sequencing of Caph2nes/nes, P53-/- and Caph2nes/nes 
P53-/- double mutant tumours. Copy number gains are shown in red, deletions 
in blue. Additional plots are shown in Figure S9. B. Frequency of whole 
chromosome aneuploidies, based on shallow whole genome sequencing in 
tumours arising on the indicated genotypes, and control DNA from aged (9 – 
15 month) Caph2nes/nes tail. Red bars indicate the mean and error bars show 
SEM. Brackets above the plot link conditions for which two-tailed t-tests gave 
significant p values (< 0.001) C. Frequency of CNAs ≥1Mb, presented as in 
panel B. Error bars link conditions for which two-tailed t-tests gave significant 
p values (< 0.03). D. Frequency of CNAs ≥30kb, presented as in panel B. 
Error bars link conditions for which two-tailed t-tests gave significant p values 
(< 0.05).  
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